D
1
2 be
3Q1
4 A, UQ10
5
6
7
8
9
10
11
121314
15
16
Q12
17
18
19
20 Depot
21
22
23
24
25
26tiss
27ring
28adip
29ood
30ipo
31elo
32se
33ure
34mp
35nes
36oints to a deficit in adipose tissue angiogenesis as a contributing factor to insulin
37ease in obesity. These emerging findings support the concept of the adipose tissue
38
39
40
4142
43
44
45
46 es and
47 ization
48 on in in
49 aste pr
50 illance
51 lood flo
52 ue and
53
54
55 network.Most of the growthof organs and tissues occurs duringdevelop-
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76subcutaneous adipose tissue mass decreases the odds of insulin resis-
77
78
79
80
81eposition into muscle,
82tion and inappropriate
83
84
Biochimica et Biophysica Acta xxx (2013) xxx–xxx
Q11
BBADIS-63743; No. of pages: 10; 4C: 3, 4, 6
Contents lists available at SciVerse ScienceDirect
Biochimica et Bi
j ourna l homepage: www.e ls
are metabolic alterations that enhance risk of metabolic disease. The
cellular and molecular mechanisms by which adipose tissue growth is
lipid metabolism are thought to cause insulin resistance and result in a
greatly increased risk of T2DM [4,5]. Thus, understanding the specific
Uto expandhas clear evolutionary advantages, enabling survival in times ofnutrient scarcity; however, concomitant with adipose tissue expansion of triglycerides, thus preventing ectopic lipid dliver and visceral fat depots. Such ectopic deposi
N
Cment, and their final size remains relatively constant through adulthood.
In contrast, adipose tissue is unique in that it can expand many-fold, to
comprise more than 40% of total body composition in obese individuals,
defined as a bodymass index of 30 or higher. The ability of adipose tissue
tance by 48%. In contrast, each SD increase in visceral adipose tissue
mass increases the odds of insulin resistance by 80% [3]. The protective
effect of expandable subcutaneous fat depots duringweight gain is like-
ly to bedue to their capacity to properly store excess calories in the form
coordinated with the expansion of its capillar
☆ This article is part of a Special Issue entitled: Modulat
and Disease.
⁎ Corresponding author at: Program in Molecular Medic
Medical School, Worcester, MA 01605, USA. Tel.: +1 50885
E-mail address: Silvia.corvera@umassmed.edu (S. Co
0925-4439/$ – see front matter © 2013 Published by El
http://dx.doi.org/10.1016/j.bbadis.2013.06.003
Please cite this article as: S. Corvera, O. Geale
Acta (2013), http://dx.doi.org/10.1016/j.bba
Thus, the growth of any
lel growth of its vascular
with increase risk, while expansion of others is associated with de-
creased risk [2]. Strikingly, each standard deviation (SD) increase in
Otion necessary for whole body homeostasis.
organ or tissue must be accompanied by paral
Capillary
Blood vessel
Hypoxia
1. Introduction
The growth and function of all tissu
pendent on their appropriate vascular
for providing the correct oxygen tensi
delivery and removal of nutrients andw
of cells involved in tissue immune surve
ical for the health of individual tissues, b
growth factors that insure the inter-tiss
R
R
E
C
TEModulation of Adipose Tissue in Health and Disease. © 2013 Published by Elsevier B.V.
organs are critically de-
. Blood flow is important
dividual tissues, for the
oducts, and for the transit
. In addition to being crit-
w delivers hormones and
inter-organ communica-
As these mechanisms may underlie the basis for adipose tissue dysfunc-
tion in metabolic disease, they comprise a fertile and exciting area of
research.
While the close association between weight gain and heightened
risk of type 2 diabetes (T2DM) is well established, not all individuals
with obesity become diabetic, and certain individuals become diabetic
after very minor weight gain [1]. This paradox is explained by the
large individual variation in the size and expandability of different adi-
pose tissue depots in humans, as expansion of some depots is associated
Weight gain v
asculature as a source of new targets for metabolic disease therapies. This article is part of a Special Issue entitled:
Vascularization
substantial amount of data p
resistance and metabolic dis
Review
Adipose tissue angiogenesis: Impact on o
Silvia Corvera ⁎, Olga Gealekman
Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, M
a b s t r a c ta r t i c l e i n f o
Article history:
Received 1 March 2013
Received in revised form 24 May 2013
Accepted 1 June 2013
Available online xxxx
Keywords:
Adipocyte
Endothelial
Vascular
Fat
The growth and function of
of expanding many-fold du
growing and proliferating
angiogenesis, where new bl
giogenesis may underlie ad
In addition, genetic and dev
pandability of diverse adipo
the adipose tissue vasculat
angiogenesis may directly i
basic mechanisms of angioge
y network are unknown.
ion of Adipose Tissue in Health
ine, University of Massachusetts
66898.
rvera).
sevier B.V.
kman, Adipose tissue angioge
dis.2013.06.003
P
R
O
O
F
sity and type-2 diabetes☆
SA
ues are critically dependent on their vascularization. Adipose tissue is capable
adulthood, therefore requiring the formation of new vasculature to supply
ocytes. The expansion of the vasculature in adipose tissue occurs through
vessels develop from those pre-existing within the tissue. Inappropriate an-
se tissue dysfunction in obesity, which in turn increases type-2 diabetes risk.
pmental factors involved in vascular patterning may define the size and ex-
tissue depots, which are also associated with type-2 diabetes risk. Moreover,
appears to be the niche for pre-adipocyte precursors, and factors that affect
act the generation of new adipocytes. Here we review recent advances on the
is, and on the role of angiogenesis in adipose tissue development and obesity. A
ophysica Acta
evie r .com/ locate /bbad is
85mechanisms by which the subcutaneous adipose tissue expands is of
86particular interest, as these could provide new approaches for therapeu-
87tic intervention in metabolic disease. Several lines of evidence indicate
88that adipose tissue growth can be limited by its vascular supply [6–8],
89raising the possibility that the angiogenic potential of specific depots
90might be critical in limiting their maximal expandability. Testing this
91hypothesis will require a deep understanding of the basic mechanisms
nesis: Impact on obesity and type-2 diabetes, Biochimica et Biophysica
T
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187of tissue oxygen tension using microelectrodes [20–22]. Using directly
188placed microelectrodes, adipose tissue in obese humans has been found
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
2 S. Corvera, O. Gealekman / Biochimica et Biophysica Acta xxx (2013) xxx–xxx
U
N
C
O
R
R
E
C
of vascularization in expanding adult tissues, and the specific regulatory
factors that operate in different adipose tissue depots.
2. Basic molecular and cellular mechanisms of angiogenesis
The de-novo formation of blood vessels during the development of
the embryo occurs through the process of vasculogenesis, in which
mesoderm-derived precursors, called angioblasts, organize into the
first primitive blood vessels. All further vessel growth during organ
and tissue development, as well as during tissue repair in adult organ-
ism, takes place through the process of angiogenesis, in which new
vessels sprout from pre-existing vasculature. It is likely therefore that
the vascularization of adipose tissue depots in adults proceeds through
angiogenic expansion of the existing vasculature, as has been shown to
occur during the formation of fat pads from implanted cells [9]. The last
few years have brought great insight into the basic molecular and
cellular mechanisms of angiogenesis [10–14], setting the stage for
the identification of factors that regulate this process to fulfill tissue
and developmental stage specific functions. Key insights into the cellular
andmolecular bases for angiogenesis, derived from experimentalmodels
such as the developing zebrafish embryo and the mouse retina, are very
briefly summarized below.
The cardinal features of angiogenesis comprise the proliferation of
endothelial cells, their directed migration through the extracellular
matrix, the establishment of intercellular junctions, the formation of
a lumen, the organization of perivascular supporting cells, the anasto-
mosis with existing vessels, and the establishment of circulation. The
cardinal initiating event is the stimulation of endothelial cell prolifer-
ation, which is mediated by the VEGF family of growth factors. These
growth factors and their receptors have been established as master
regulators of endothelial cell growth. In particular, VEGF-A, acting
through the VEGFR2 (VEGF receptor 2, also known as KDR in humans
or Flk1 in mice) represents the most potent mitogenic and chemo
attractant signal for endothelial cells. In response to VEGF-A gradients,
endothelial cells divide, and acquire a specific phenotype (tip cell phe-
notype) characterized by the formation of branches and numerous
filopodia, which extend towards the direction in which the endothelial
cell migrates. The action of VEGFs and their receptors are critically
controlled by the Notch signaling pathway, which modulates the re-
sponsiveness of endothelial cells to VEGF, and their subsequent special-
ization. Thus, tip cells are characterized by high levels of expression of
Delta-like 4 (Dll4), which is a ligand for Notch. The stimulation of
Notch signaling by Dll4 in the tip cell suppresses VEGF signaling in ad-
jacent cell, resulting in the acquisition of a stalk-cell phenotype. The
continuous dynamic interaction between VEGF, Notch and Dll4 results
in the development of angiogenic sprouts. Newly formed sprouts are
then stabilized by interactions with smooth muscle cells and pericytes,
and become lumenized, through processes that appear to involve junc-
tional trans-membrane proteins such as VE-cadherin, as well as matrix
proteins which are broken down and reorganized dynamically during
vessel growth [14]. Newly formed sprouts anastomose with existing
vessels, thus extending tissue microcirculation.
While the basic steps of angiogenesis outlined above are expected
to operate, it is likely that the vascular network of each organ and tissue
will be established through key tissue-specificmechanisms. A prominent
example is the regulation of angiogenesis in the central nervous system,
where specific G-protein coupled receptors are uniquely expressed
and play dominant roles in angiogenic vascularization of the developing
brain [15,16].Whatmechanisms operate in adipose tissue, and how they
modulate the basic steps of angiogenesis described above, are outstand-
ing questions in adipose tissue biology.
3. Adipose tissue angiogenesis; what are the triggers?
One of the guiding questions for understanding angiogenic growth
in adipose tissue is whether themechanisms involved during embryonic
Please cite this article as: S. Corvera, O. Gealekman, Adipose tissue angioge
Acta (2013), http://dx.doi.org/10.1016/j.bbadis.2013.06.003
to be hypoxic [23]. Other findings consistent with a role for hypoxia are
that the expression and secretion of pro-angiogenic factors by cultured
adipocytes are strongly stimulated under low oxygen culture condi-
tions [24]. These results suggest that, in a manner analogous to that oc-
curring during tumor growth, adipose tissue hypoxia might be a driver
for angiogenesis. However, the reported levels of hypoxia in human
adipose tissue are relatively small, and one study actually finds increased
oxygen tension in adipose tissue of obese subjects [25]. Moreover, it has
been previously noted that expansion of adipose tissue in response to
HFD is not accompanied by a corresponding increased blood flow [26].
Collectively, these results suggest that the response to hypoxia in adipose
tissue may be insufficient to elicit sufficient compensatory angiogenic
expansion.
A powerful, direct approach to defining the role of hypoxia in adipose
tissue growth has been the tissue-specific overexpression and ablation of
both HIF-1α and HIF-1β. Overexpression of a constitutively active form
of HIF-1α in adipose tissue failed to induce a pro-angiogenic response;
rather, it resulted in a fibrotic response and an increase in local inflam-
mation [27]. Conversely, ablation of HIF-1α or HIF-1β (ARNT) in adipose
tissue reduced fat formation, and protected from HFD-induced obesity
and insulin resistance [28,29]. Furthermore, anti-sense mediated deple-
tion of HIF-1α in obese mice resulted in amelioration of HFD-induced
insulin resistance [30], as did pharmaceutical inhibition of HIF-1α, as
well as inducible expression of a dominant negative form [31]. Overall,
these results are consistent with a model where adipose tissue hypoxia
induces HIF-1α, which induces a fibrotic and inflammatory response
rather than a compensatory pro-angiogenic response. Nevertheless,
E
D
P
R
O
O
F
and early postnatal development are similar to those involved in re-
sponse to excess calorie consumption in adults. In both cases, two
broad possibilities can be considered: First, angiogenic expansion may
be triggered in response to signals emanating from proliferating and en-
larging adipocytes. The second possibility is that angiogenic growth is
triggered by developmental and/or metabolic signals, and parallels or
precedes adipocyte proliferation and enlargement (Fig. 1). These two
possibilities are not mutually exclusive, and in all likelihood tissue ex-
pansion involves both local cues arising from expanding adipocytes, as
well as distant cues reflecting the developmental and metabolic states
of the whole organism.
The first option, in which vascular growth ensues secondarily to
parenchymal growth is the canonical model for oncogenic vasculari-
zation [17–19]. In this model, the rapid growth of tumor cells and
the formation of a tumor mass elicit regions of hypoxia. Hypoxia is
sensed through multiple mechanisms, prominent amongst which is
the inactivation of oxygen-dependent prolyl-hydroxylases. Inactivation
of these enzymes results in the protection of HIF-1α from proteolytic
degradation, allowing its dimerization with constitutively expressed
HIF-1β to form the functional transcription factorHIF1. This transcription
factor potently activates a program of hypoxia adaptation, which in-
cludes decreased transcription and translation and increased VEGF-A
expression. The angiogenic expansion of the vasculature in response to
VEGF-A enhances blood flow and relieves hypoxia, allowing further
tumor growth. This model, in which tumor growth is absolutely depen-
dent on stimulation of angiogenesis, forms the basis for the development
and use of anti-angiogenic therapies in cancer [11].
4. Role of hypoxia in adipose tissue angiogenesis
Themost relevant evidence consistentwith a possible role for hypoxia
in adipose tissue angiogenesis are the findings that adipose tissue in ro-
dents becomes hypoxic in response to obesity that is rapidly induced
by high fat diet (HFD). This finding has been documented repeatedly,
using both chemical indicators of hypoxia, as well as direct monitoring
216HIF-1α may be relevant for the growth and maintenance of brown
nesis: Impact on obesity and type-2 diabetes, Biochimica et Biophysica
T217 adipose tissue, as expression of dominant-negative form of HIF-1α218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
rowt
sue
cha
te h
3S. Corvera, O. Gealekman / Biochimica et Biophysica Acta xxx (2013) xxx–xxx
impairs thermogenesis and energy expenditure [32].
Fig. 1. Two possible models for the stimulation of angiogenesis during adipose tissue g
generating areas of tissue hypoxia. Hypoxia, and/or other factors released from the tis
tissue architecture and function. B. Increased calorie consumption results in systemic
adipose tissue. Increased angiogenesis facilitates lipid storage in adipocytes and adipocy
opment of hypoxia and metabolic stress.
U
N
C
O
R
R
E
C5. Role of VEGF in adipose tissue angiogenesis
In tumor angiogenesis, hypoxia-induced HIF1 stabilization activates
VEGF transcription and secretion, which in turn stimulates angiogene-
sis. The induction of fibrosis and inflammation by HIF-1α in adipose tis-
sue suggests that the stimulation of VEGF productionmay be controlled
by different mechanisms, which are insufficiently activated during the
rapid expansion induced by high-fat diets or hyperphagia. Consistent
with this notion, transgenic overexpression of VEGF in adipose tissue
results in increased vascularization, decreased inflammation, and ame-
lioration of HFD-induced insulin resistance [33–35]. More strikingly,
induced expression of VEGF-A in adipose tissue of animals previously
rendered obese and insulin resistant reversed the establishedmetabolic
defects [33]. Expression of VEGF-A also caused the generation of adipo-
cytes expressing UCP1, which are more similar to brown adipose tissue
and have a highermetabolic rate, and result in lowerweight gain under
conditions of HFD [36].
Conversely, ablation of VEGF in adipose tissue resulted in hypo-
perfused adipose tissue, which displayed higher levels of inflammato-
ry markers even under normal chow diet. In response to HFD feeding
adipose tissue from VEGF-ablated animals developed much greater
inflammation compared to controls [33]. This greater inflammation
was accompanied by adipocyte death, a net decrease in depot size,
and marked deterioration of glucose tolerance and insulin sensitivity.
This enhanced inflammatory phenotype is similar to that observed in
animals overexpressing HIF-1α. In aggregate, these findings suggest a
model where insufficient angiogenesis during high-fat diet leads to
hypoxia, HIF-1α expression, inflammation and adipose tissue dysfunc-
tion (Fig. 2). In addition, these studies clearly demonstrate that increased
VEGF-A production and increased vascularization enable adipose tissue
to adapt to rapid expansion caused by acutely increased caloric intake,
Please cite this article as: S. Corvera, O. Gealekman, Adipose tissue angioge
Acta (2013), http://dx.doi.org/10.1016/j.bbadis.2013.06.003
E
D
P
R
O
O
F
and protect from the development of insulin resistance and glucose
intolerance.
These results raise the questions: whatmechanisms limit the expres-
h. A. Increased calorie consumption results in adipocyte hypertrophy and hyperplasia,
stimulate angiogenesis. Angiogenesis results in mitigation of hypoxia and appropriate
nges in trophic factors such as insulin, which directly stimulate angiogenesis within
yperplasia. The simultaneous expansion of adipocytes and vasculature prevents devel-
252sion of VEGF in adipose tissue, and do differences in VEGF production ac-
253count for the variation in human adipose tissue expandability and
254subsequent protection from inflammation and metabolic dysfunction?
255Although some studies report decreased levels of VEGF gene expression
256in obese humans [23], others report higher levels of expression of
257VEGF-A in both subcutaneous and omental fat in obese compared
258to lean subjects, and a higher level in omental adipose tissue from
259obese insulin-sensitive compared to obese insulin-resistant individuals
260[37]. Unpublished results from our own group studying obese female
261subje